Press release
India Biosimilar Market Size, Growth Analysis, Industry Report 2025-2033
Market Overview 2025-2033
The India biosimilar market size reached USD 866.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 3,662.9 Million by 2033, exhibiting a growth rate (CAGR) of 17.38% during 2025-2033. The market is expanding rapidly, driven by rising healthcare needs, patent expirations, and cost-effective treatment options. Key trends include increasing regulatory approvals, growing adoption in oncology and autoimmune diseases, and investments in advanced biomanufacturing.
Key Market Highlights:
✔️ Strong market expansion driven by rising healthcare demand & affordability
✔️ Growing adoption of biosimilars in oncology & autoimmune disorders
✔️ Increasing regulatory approvals supporting market growth
✔️ Advancements in biomanufacturing enhancing production efficiency
✔️ Expanding research collaborations to drive innovation & accessibility
Request for a sample copy of this report: https://www.imarcgroup.com/india-biosimilar-market/requestsample
India Biosimilar Market Trends and Drivers:
The India biosimilar market is witnessing rapid growth, driven by the increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders, which require long-term biologic treatments. The high costs of original biologics have made biosimilars a cost-effective alternative, improving accessibility to advanced therapies for a wider patient population.
Government initiatives to enhance healthcare access and the growing adoption of biosimilars in public health programs are further fueling market expansion. Additionally, the expiration of patents for major biologic drugs has created opportunities for Indian pharmaceutical companies to develop and launch biosimilars in both domestic and international markets.
Key trends shaping the Indian biosimilar market include advancements in biotechnology research, enabling the production of high-quality and affordable biosimilars. Indian pharmaceutical firms are heavily investing in R&D and forming strategic alliances with global players to strengthen their biosimilar portfolios and expand their market reach. Increasing acceptance among healthcare professionals and patients, driven by growing awareness and confidence in biosimilars' safety and efficacy, is also a major factor propelling market growth.
Furthermore, Indian regulatory authorities are streamlining approval processes to support the faster development and commercialization of biosimilars. As the demand for affordable biologic therapies continues to grow, India is positioned to become a major player in the global biosimilar market in the coming years.
Checkout Now: https://www.imarcgroup.com/checkout?id=21512&method=1337
India Biosimilar Market Segmentation:
The report segments the market based on product type, distribution channel, and region:
Study Period:
Base Year: 2024
Historical Year: 2019-2024
Forecast Year: 2025-2033
Breakup by Molecule:
• Infliximab
• Insulin Glargine
• Epoetin Alfa
• Etanercept
• Filgrastim
• Somatropin
• Rituximab
• Follitropin Alfa
• Adalimumab
• Pegfilgrastim
• Trastuzumab
• Bevacizumab
• Others
Breakup by Indication Insights:
• Auto-Immune Diseases
• Blood Disorder
• Diabetes
• Oncology
• Growth Deficiency
• Female Infertility
• Others
Breakup by Manufacturing Type:
• In-house Manufacturing
• Contract Manufacturing
Breakup by Region:
• North India
• West and Central India
• South India
• East and Northeast India
Ask Analyst & Browse full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=21512&flag=C
Competitive Landscape:
The market research report offers an in-depth analysis of the competitive landscape, covering market structure, key player positioning, top winning strategies, a competitive dashboard, and a company evaluation quadrant. Additionally, detailed profiles of all major companies are included.
About Us:
IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.
IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
The India biosimilar market size reached USD 866.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 3,662.9 Million by 2033, exhibiting a growth rate (CAGR) of 17.38% during 2025-2033. The market is expanding rapidly, driven by rising healthcare needs, patent expirations, and cost-effective treatment options. Key trends include increasing regulatory approvals, growing adoption in oncology and autoimmune diseases, and investments in advanced biomanufacturing.
Key Market Highlights:
✔️ Strong market expansion driven by rising healthcare demand & affordability
✔️ Growing adoption of biosimilars in oncology & autoimmune disorders
✔️ Increasing regulatory approvals supporting market growth
✔️ Advancements in biomanufacturing enhancing production efficiency
✔️ Expanding research collaborations to drive innovation & accessibility
Request for a sample copy of this report: https://www.imarcgroup.com/india-biosimilar-market/requestsample
India Biosimilar Market Trends and Drivers:
The India biosimilar market is witnessing rapid growth, driven by the increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders, which require long-term biologic treatments. The high costs of original biologics have made biosimilars a cost-effective alternative, improving accessibility to advanced therapies for a wider patient population.
Government initiatives to enhance healthcare access and the growing adoption of biosimilars in public health programs are further fueling market expansion. Additionally, the expiration of patents for major biologic drugs has created opportunities for Indian pharmaceutical companies to develop and launch biosimilars in both domestic and international markets.
Key trends shaping the Indian biosimilar market include advancements in biotechnology research, enabling the production of high-quality and affordable biosimilars. Indian pharmaceutical firms are heavily investing in R&D and forming strategic alliances with global players to strengthen their biosimilar portfolios and expand their market reach. Increasing acceptance among healthcare professionals and patients, driven by growing awareness and confidence in biosimilars' safety and efficacy, is also a major factor propelling market growth.
Furthermore, Indian regulatory authorities are streamlining approval processes to support the faster development and commercialization of biosimilars. As the demand for affordable biologic therapies continues to grow, India is positioned to become a major player in the global biosimilar market in the coming years.
Checkout Now: https://www.imarcgroup.com/checkout?id=21512&method=1337
India Biosimilar Market Segmentation:
The report segments the market based on product type, distribution channel, and region:
Study Period:
Base Year: 2024
Historical Year: 2019-2024
Forecast Year: 2025-2033
Breakup by Molecule:
• Infliximab
• Insulin Glargine
• Epoetin Alfa
• Etanercept
• Filgrastim
• Somatropin
• Rituximab
• Follitropin Alfa
• Adalimumab
• Pegfilgrastim
• Trastuzumab
• Bevacizumab
• Others
Breakup by Indication Insights:
• Auto-Immune Diseases
• Blood Disorder
• Diabetes
• Oncology
• Growth Deficiency
• Female Infertility
• Others
Breakup by Manufacturing Type:
• In-house Manufacturing
• Contract Manufacturing
Breakup by Region:
• North India
• West and Central India
• South India
• East and Northeast India
Ask Analyst & Browse full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=21512&flag=C
Competitive Landscape:
The market research report offers an in-depth analysis of the competitive landscape, covering market structure, key player positioning, top winning strategies, a competitive dashboard, and a company evaluation quadrant. Additionally, detailed profiles of all major companies are included.
About Us:
IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.
IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
